Pharmaceutical Information |
Drug Name |
Methenamine |
Drug ID |
BADD_D01411 |
Description |
Methenamine is a heterocyclic organic compound with a cage-like structure similar to adamantane. In salt form it is used for the treatment of urinary tract infection (Example: methenamine hippurate which is the hippuric acid salt of methenamine). |
Indications and Usage |
For prophylactic or suppressive treatment of frequently recurring urinary tract infections when long-term therapy is considered necessary. This drug is not used to treat infection and should only be used after appropriate eradication of infection with antimicrobial agents. |
Marketing Status |
approved; vet_approved |
ATC Code |
J01XX05 |
DrugBank ID |
DB06799
|
KEGG ID |
D00393
|
MeSH ID |
D008709
|
PubChem ID |
4101
|
TTD Drug ID |
D02LJR
|
NDC Product Code |
51927-0093; 61960-6008; 49452-4558; 43285-0002 |
UNII |
J50OIX95QV
|
Synonyms |
Methenamine | Hexamine | Hexamethylenetetramine | Hexamine Silver | Silver, Hexamine | Silver Methenamine | Methenamine, Silver | Methenamine Silver | Silver, Methenamine | Urotropin | Aminoform |
|
Chemical Information |
Molecular Formula |
C6H12N4 |
CAS Registry Number |
100-97-0 |
SMILES |
C1N2CN3CN1CN(C2)C3 |
Chemical Structure |
|
|
ADRs Induced by Drug |
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|